Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
Mrozek E, Ramaswamy B, Young D, Rhoades CA, Kendra K, Allen J, Moore T, Hauger M, Watson H, Merriman N, Nadella P, Villalona-Calero M, Shapiro CL.
Mrozek E, et al. Among authors: allen j.
Clin Breast Cancer. 2006 Jun;7(2):141-5. doi: 10.3816/CBC.2006.n.023.
Clin Breast Cancer. 2006.
PMID: 16800973
Clinical Trial.